Cystatin C and cathepsin B in human colon carcinoma: Expression by cell lines and matrix degradation
- 21 October 1992
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 52 (4) , 645-652
- https://doi.org/10.1002/ijc.2910520425
Abstract
Expression of the cysteine proteinase cathepsin B and its physiological inhibitor cystatin C was analyzed in vitro in I human fibrosarcoma and 4 human colon carcinoma cell lines. Cystatin C antigen as well as cathepsin B activity were detected in the conditioned media of the 5 cell lines. The corresponding cell extracts expressed high levels of cathepsin B activity, whereas only trace amounts of cystatin C antigen could be found. Northern-blot analysis revealed the presence in the 5 cell lines of a 0.8-kb cystatin C mRNA transcript and 2 cathepsin B transcripts of 2.3 and 4.3 kb. Pepsin treatment of tumor-cell-released cathepsin B induced an average 7.3-fold increase in activity, indicating that the enzyme was mainly present as a latent form in conditioned medium. The pepsin-activated cathepsin B from one colon carcinoma cell line was further characterized using the cysteine proteinase inhibitors E-64, recombinant cystatin C, a cystatin-C-derived peptidyl inhibitor (Z-LVG-CHN2), and cathepsin-B-specific diazomethyl ketone inhibitors (Z-FT(OBzl)-CHN2, Z-FS(OBzl)-CHN2). This activity was totally neutralized by recombinant cystatin C, suggesting a potential for interaction between released extracellular cathepsin B and cystatin C. In vitro assays of degradation of extracellular matrix showed that cyrteine proteinase inhibitors could decrease matrix degradation induced by pepsin-activated conditioned media. With colon cells, this inhibition was not observed, indicating a requirement for an extracellular activation of latent cathepsin B. Our data provide evidence that cystatin C and latent cathepsin B are both released extracellularly by colon carcinoma cells in vitro. They suggest that cystatin C and cathepsin B interactions may participate, in an as yet unelucidated way, in the modulation of the invasive phenotype of human colonic tumors.Keywords
This publication has 22 references indexed in Scilit:
- Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin CPublished by Wiley ,2001
- Membrane-associated cathepsin L: A role in metastasis of melanomasBiochemical and Biophysical Research Communications, 1989
- Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcomaBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Degradation of laminin by human tumor cathepsin BClinical & Experimental Metastasis, 1989
- Immunodetection of cathepsins b and l present in and secreted from human pre‐malignant and malignant colorectal tumour cell linesInternational Journal of Cancer, 1989
- Identification of latent procathepsins B and L in microsomal lumen: Characterization of enzymatic activation and proteolytic processing in vitroArchives of Biochemistry and Biophysics, 1988
- Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogenScandinavian Journal of Clinical and Laboratory Investigation, 1987
- Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascadeCell, 1986
- The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitorsBiochemical and Biophysical Research Communications, 1984
- An exploration of the primary specificity site of cathepsin BArchives of Biochemistry and Biophysics, 1983